MR imaging findings of iron overload

Radiographics

Volumn 29, Issue 6, 2009, Pages 1575-1589

  Queiroz Andrade, Marcony ^a   Blasbalg, Roberto ^a   Ortega, Cinthia D ^a   Rodstein, Marco A M ^a   Baroni, Ronaldo H ^a   Rocha, Manoel S ^a   Cerri, Giovanni G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; IMAGE ENHANCEMENT; IRON OVERLOAD; LIVER; LIVER DISEASE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

HUMANS; IMAGE ENHANCEMENT; IRON OVERLOAD; LIVER; LIVER DISEASES; MAGNETIC RESONANCE IMAGING;

EID: 77449106070     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.296095511     Document Type: Article

References (46)

1. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-1995.
2. Siah CW, Ombiga J, Adams LA, Trinder D, Olynyk JK. Normal iron metabolism and the pathophysiology of iron overload disorders. Clin Biochem Rev 2006;27:5-16.
3. Pietrangelo A. Haemochromatosis. Gut 2003;52 (suppl 2):ii23-ii30.
4. Jensen PS. Hemochromatosis: a disease often silent but not invisible. AJR Am J Roentgenol 1976;126: 343-351.
5. Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron overload screening in a racially diverse population. N Engl J Med 2005;352: 1769-1778.
6. Njajou OT, Alizadeh BZ, van Duijn CM. Is genetic screening for hemochromatosis worthwhile? Eur J Epidemiol 2004;19:101-108.
7. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutation. J Med Genet 1997;34:275-278.
8. Siegelman ES, Mitchel DG, Semelka RC. Abdominal iron deposition: metabolism, MR findings, and clinical importance. Radiology 1996;199:13-22.
9. Adams P, Brissot P, Powell LW. EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000;33:485-504.
10. Brissot P, Bourel M, Herry D, et al. Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology 1981; 80:557-565.
11. Crawford DH, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C28Y mutation. Gastroenterology 1998;114:1003-1008.
12. Alústiza JM, Artetxe J, Castiella A, et al. MR quantification of hepatic iron concentration. Radiology 2004;230:479-484.
13. Guyader D, Gandon Y, Deugnier Y, et al. Evaluation of computed tomography in the assessment of liver iron overload: a study of 46 cases of idiopathic hemochromatosis. Gastroenterology 1989;97:737-743.
14. Howard JM, Ghent CN, Carey LS, Flanagan PR, Valberg LS. Diagnostic efficacy of hepatic computed tomography in the detection of body iron overload. Gastroenterology 1983;84:209-215.
15. Goldman IS, Winkler ML, Raper SE, et al. Increased hepatic density and phospholipidosis due to amiodarone. AJR Am J Roentgenol 1985;144:541-546.
16. De Maria M, De Simone G, Laconi A, Mercadante G, Pavone P, Rossi P. Gold storage in the liver: appearance on CT scans. Radiology 1986;159:355-356.
17. Gomori JM, Horev G, Tamary H, et al. Hepatic iron overload: quantitative MR imaging. Radiology 1991; 179:367-369.
18. Gandon Y, Guyader D, Heautot JF, et al. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology 1994;193:533-538.
19. Gandon Y, Olivié D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363:357-362.
20. Alústiza JM, Castiella A, De Juan MD, Emparanza JI, Artetxe J, Uranga M. Iron overload in the liver diagnostic and quantification. Eur J Radiol 2007; 61:499-506.
21. Westphalen AC, Qayyum A, Yeh BM, et al. Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology 2007;242: 450-455.
22. Ernst O, Sergent G, Bonvarlet P, Canva-Oelcambre V, Paris JC, L'Hermin C. Hepatic iron overload: diagnosis and quantification with MR imaging. AJR Am J Roentgenol 1997;168:1205-1208.
23. Bonkovsky HL, Rubin RB, Cable EE, Davidoff A, Rijcken TH, Stark DD. Hepatic iron concentration: noninvasive estimation by means of MR imaging. Radiology 1999;212:227-234.
24. Gandon Y. Iron, liver and MRI. University of Rennes Web site. http://www.radio.univ-rennes1.fr/Sources/EN/Hemo.html. Updated June 10, 2001. Accessed January 25, 2009.
25. Siegelman ES, Mitchel DG, Rubin R, et al. Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imaging. Radiology 1991;179:361-366.
26. Siegelman ES, Mitchell RG, Outwater E, Munoz SJ, Rubin R. Idiopathic hemochromatosis: MR imaging findings in cirrhotic and precirrhotic patients. Radiology 1993;188:637-641.
27. Ben Salem D, Cercueil JP, Ricolfi F, Krausé D. Case 75: erythropoietic hemochromatosis. Radiology 2004;233:116-119.
28. Midiri M, Lo Casto A, Sparacia G, et al. MR imaging of pancreatic changes in patients with transfusion-dependent beta-thalassemia major. AJR Am J Roentgenol 1999;173:187-192.
29. Hann HW, Kim CY, London WT, Blumberg BS. Increased serum ferritin in chronic liver disease: a risk factor for primary hepatocellular carcinoma. Int J Cancer 1989;43:376-379.
30. Ito K, Mitchell DG, Gabata T, et al. Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging. Radiology 1999;212:235-240.
31. Roubidoux MA. MR imaging of hemorrhage and iron deposition in the kidney. RadioGraphics 1994; 14:1033-1044.
32. Jeong JY, Kim SH, Lee HJ, Sim JS. Atypical low-signal-intensity renal parenchyma: causes and patterns. RadioGraphics 2002;22:833-846.
33. Lee JW, Kim SH, Yoon CJ. Hemosiderin deposition on the renal cortex by mechanical hemolysis due to malfunctioning prosthetic cardiac valve: report of MR findings in two cases. J Comput Assist Tomogr 1999;23:445-447.
34. Roubidoux MA. MR of kidney, liver, and spleen in paroxysmal nocturnal hemoglobinuria. Abdom Imaging 1994;19:168-173.
35. Leonardi P, Ruol A. Renal hemosiderosis in the hemolytic anemias: diagnosis by means of needle biopsy. Blood 1960;16:1029-1038.
36. Stark DD. Hepatic iron overload: paramagnetic pathology. Radiology 1991;179:333-335.
37. Yoon DY, Choi BI, Han JK, Han MC, Park MO, Suh SJ. MR findings of secondary hemochromatosis: transfusional vs erythropoietic. J Comput Assist Tomogr 1994;18:416-419.
38. Levenson H, Greensite F, Hoefs J, et al. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy. AJR Am J Roentgenol 1991;156:307-312.
39. Horton KM, Bluemke DA, Hruban RH, Soyer P, Fishman EK. CT and MR imaging of benign hepatic and biliary tumors. RadioGraphics 1999;19:431-451.
40. Chan AT, Ma J, Tranah GJ, et al. Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women. J Natl Cancer Inst 2005;97:917-926.
41. Shaheen NJ, Silverman LM, Keku T, et al. Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J Natl Cancer Inst 2003;95:154-159.
42. Stevens RG, Jones DY, Micozzi MS, Taylor PR. Body iron stores and the risk of cancer. N Engl J Med 1988;319:1047-1052.
43. Velazquez I, Alter BP. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol 2004;77:257-267.
44. Maves CK, Caron KH, Bisset GS 3rd, et al. Splenic and hepatic peliosis: MR findings. AJR Am J Roentgenol 1992;158:75-76.
45. Elsayes KM, Narra VR, Yin Y, Mukundan G, Lammle M, Brown JJ. Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging. RadioGraphics 2005;25:1299-1320.
46. Bagheri SA, Boyer JL. Peliosis hepatis associated with androgenic-anabolic steroid therapy: a severe form of hepatic injury. Ann Intern Med 1974;81: 610-618.